---
layout: post
title: "腾盛博药-B(02137.HK)获Invesco Advisers, Inc.增持24.15万股"
date: 2022-01-12 07:29:19 +0800
categories: gelonghui
tags: 格隆汇新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02137" data-code="02137|116|5" data-code2="02137|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02137&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02137_0" data-code="K 02137|116|5" data-code2="K 02137|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>根据联交所最新权益披露资料显示，2022年1月6日，腾盛博药-B(02137.HK)获Invesco Advisers， Inc。在场内以每股均价33.4943港元增持24.15万股，涉资约808.89万港元。</p>
 <p>增持后，Invesco Advisers， Inc。最新持股数目为4335.17万股，持股比例由5.98%上升至6.01%。</p>
 <p align="center"><br/></p><p class="em_media">（文章来源：格隆汇）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201122244379750>

[返回格隆汇新闻](//finews.withounder.com/category/gelonghui.html)｜[返回首页](//finews.withounder.com/)